Objective: To investigate long-term mortality rates and causes of death in individuals diagnosed with type 1 diabetes before the age of 15 years during the period 1989-2012 or known to paediatric diabetes teams in 1989, in Northern Ireland.
| INTRODUCTION
Despite advances in treatment and management, an excess mortality in people diagnosed with type 1 diabetes compared to the general population persists. Most excess mortality in young people with type 1 diabetes has been attributed to acute diabetes-related complications, mainly diabetic ketoacidosis (DKA) and, to a lesser extent, hypoglycaemia. 1 As both of these complications are largely preventable through education and improved glycaemic control, as well as increased awareness, one might anticipate a decline in such deaths in recent years.
Other causes of excess mortality that have been reported in older patients with diabetes include renal disease and cardiovascular disease (CVD), both late complications of diabetes. 1 In addition, a high number of drug-related deaths among type 1 diabetes subjects compared to the general population has been reported. 2 With previous reports that the incidence of type 1 diabetes is increasing both in Europe 3 and worldwide, 4 it is important that mortality in these individuals is monitored to determine if current treatments for type 1 diabetes are effective in reducing excess deaths.
A number of population-based studies investigating mortality in patients with type 1 diabetes diagnosed in childhood and adolescence have been published in recent years but most have relatively short follow-up after diagnosis. 5 Larger studies with longer follow-up permit investigation of trends in mortality rates over time. In this study, we aim to investigate mortality in type 1 diabetes diagnosed in childhood in Northern Ireland. gov.uk/demography/default.asp.htm). Standardized mortality ratios (SMRs) were calculated as the ratio of total observed to total expected deaths and absolute mortality rates per 1000 person-years were also calculated. The 95% confidence intervals (CIs) for SMRs and absolute rates were derived from exact 95% CIs for Poisson distribution counts and ratios of 2 SMRs with 95% CIs were also calculated. 7 Mortality was reported by sex, cohort subgroup (retrospective or prospective), attained age, time since diagnosis, and calendar period.
| PATIENTS AND METHODS
Poisson regression likelihood ratio tests were used to investigate if SMRs differed significantly between subgroups. Cause-specific SMRs were also calculated.
| RESULTS
There were 48 cases (20 prospective and 28 retrospective) that could not be linked, for 21 of which (5 prospective and 16 retrospective)
no Health and Care number could be found. All were excluded from the analysis as were 2 patients for whom consent was withheld.
Three deaths occurring at the time of diagnosis were also excluded from all analyses. In total, 3129 cases of childhood type 1 diabetes
were included in the analysis providing 39 764 person-years of follow-up (median follow-up, 12.1 years, interquartile range 5.9-20.1 years). There were slightly more males than females (51%). Of these patients, 2502 were prospectively added to the register from 1989 onwards while the remaining 627 patients were added retrospectively. In total, 246 (8%) subjects were lost to follow-up at the time of their move to another part of the UK or their emigration to another country.
| ALL CAUSE-MORTALITY
Overall, there were 59 deaths during the study follow-up (1.5 deaths per 1000 person-years). Results from the person-years at risk analysis are shown in Table 1 . The 59 deaths in the cohort compared to 19.9 deaths expected from the background population rates gave an overall SMR of 296 (95% CI 226-382). The SMR in females was significantly higher (χ 2 = 13.43, df = 1, P < . Excess mortality did not appear to be associated with attained age, time since diagnosis, or calendar period. Absolute mortality rates increased with age and duration of type 1 diabetes.
| CAUSE-SPECIFIC MORTALITY
Diabetes was mentioned on 42 of the 59 death certificates (71%).
Over half of the deaths (56%) were judged to be related to diabetes or possibly related to diabetes. The majority of diabetes-related deaths were due to acute complications (n = 24 [41%]). DKA was the most common acute complication (n = 15) and 8 deaths were due to hypoglycaemia. Another death was categorized as an uncertain acute complication because the postmortem report was inconclusive. Only 6 deaths (10%) were related to late complications of diabetes, a reflection of the relatively young age of the cohort. Three of the deaths were deemed possibly related to diabetes although the exact role played by diabetes could not be determined due to uncertainties about the cause of death. There were 26 (n = 44%) deaths that were classified as unrelated to diabetes.
Eight of the 30 deaths with diabetes coded as the underlying cause could be reassigned to another cause mentioned on the death certificate (4 due as CVD, 2 as accident and violence including suicide, and 2 as chronic renal disease). 
| DISCUSSION
The primary aim of this follow-up study was to investigate mortality in subjects diagnosed with type 1 diabetes before the age of 15 years in Northern Ireland. During an extensive 24 years of follow-up, there was a 3-fold excess in mortality in patients with type 1 diabetes compared to the general population (SMR 296, 95% CI 229-382). Significant excess was observed in both prospective and retrospective groups and in each time since diagnosis category.
Our recent systematic review of mortality in young people diagnosed with type 1 diabetes showed that, while some of the studies reported similar excess in deaths, other studies in the review showed a much higher excess of deaths. 8 These latter findings were usually associated with older studies and studies in countries with higher infant mortality rates and lower health expenditures. 8 More recently published studies [9] [10] [11] [12] have also shown higher excess mortality in young people with type 1 diabetes compared to our own study, but these studies pertained to patients with an earlier calendar period of diagnosis.
Despite finding that females had a significantly higher risk of mortality than males compared to the general population (SMR = 534 vs 202), absolute mortality rates were similar (1.5 per 1000 personyears in both sexes). Such higher excesses relative to the lower background population death rates in females has been observed in other studies, 5, [13] [14] [15] although the absolute numbers of excess deaths in each sex were similar. This finding is an indication that the low mortality experienced in females in the background population is not mirrored in women with type 1 diabetes, as absolute mortality rates were similar in the 2 sexes.
We found that the risk of death was significantly higher in both prospective and retrospective groups compared to the general population (SMRs = 282 and 312, respectively). As expected, most deaths due to late complications of diabetes, including CVD and chronic renal failure, occurred in the retrospective group. Subjects in this group were generally older than the prospective cases and had a longer duration of diabetes with diagnosis occurring prior to 1989. However, 1 patient in the prospective cohort died from end-stage renal disease after 21 years of diabetes, highlighting that deaths due to chronic complications of diabetes can occur at younger ages. Given the fact that the cohort under study had a maximum follow-up of 24 years, and that only 5% of follow-up occurred beyond the age of 35 years, it is not surprising that few deaths due to late complications occurred.
Many diabetes-related deaths are now preventable through achieving optimum glycated haemoglobin (HbA1c) levels. Sandahl et al 9 identified baseline HbA1c as a significant predictor of mortality with a 38% increase in risk of death for every 1% increase in HbA1c.
With the implementation of intensive education programmes and insulin regimens in recent years, one might anticipate a decrease in the rates of both DKA and severe hypoglycaemia. Thus, it is of major concern that almost a quarter (24%) of deaths were due to potentially reported a 3-to 5-fold increase in risk of deaths related to alcohol and drug misuse. Another study investigating mortality in individuals with type 1 diabetes found a high proportion (25%) of alcohol and drug-related deaths in patients diagnosed before 15 years of age at 20 years duration of diabetes. 15 In this study, we found that drug or alcohol use was mentioned in 15% of the death certificates or postmortem reports in Northern Ireland. It is difficult to know the exact role of alcohol and drug misuse in these patients' deaths. Alcohol consumption is known to increase the risk of an immediate and prolonged hypoglycaemia 24 but it may not necessarily be mentioned in the registered causes of death. This may be particularly pertinent to
Northern Ireland due to the high level of alcohol consumption among young people. 25, 26 We speculate that some young patients living with this long-term condition, unaware of the hazards of alcohol excess, may abuse alcohol potentially placing their safety and well-being at risk. It is important that education and support is provided for patients to raise awareness of the risk of alcohol consumption and the effect it can have on metabolic control.
A major strength of this study is that it is unlikely that any deaths would have been missed as might have occurred if only death certificates mentioning diabetes had been used to ascertain mortality. 27 Furthermore, the availability of death certificates and autopsy reports One limitation of this study is that 246 subjects who were lost to follow-up and this 8% of the cohort were consequently censored at their date of emigration from Northern Ireland. The absolute mortality in this cohort may consequently be underestimated as a higher proportion of subjects who emigrated were in the older retrospective subgroup, but our person-years approach to analysis takes age into account so our SMRs should not be affected as much by this source of bias. Lastly, despite the availability of death certificates and autopsy reports, it was still not possible to determine whether some deaths were directly attributed to diabetes due to difficulty in interpreting glucose levels postmortem. 28 In conclusion, our data show that there is still a significant excess in mortality in type 1 diabetes patients in Northern Ireland. With a high proportion of deaths due to DKA or hypoglycaemia, continuing efforts should be made to raise awareness and educate patients in order to improve blood glucose control and reduce the risk of death due to these preventable complications.
